These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16475042)

  • 1. Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy.
    Goldhaber SZ
    J Thromb Thrombolysis; 2006 Feb; 21(1):51-2. PubMed ID: 16475042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The standard is still the standard or why an INR of 2-3 is still the optimal intensity for secondary prevention of venous thromboembolism.
    Kovacs MJ
    J Thromb Thrombolysis; 2006 Feb; 21(1):53-6. PubMed ID: 16475043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low intensity warfarin: is it clinically useful in venous thromboembolism management?
    Bauer KA
    Br J Haematol; 2004 Oct; 127(2):155-8. PubMed ID: 15461620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
    Ridker PM
    Vasc Med; 1998; 3(1):67-73. PubMed ID: 9666536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of low-intensity warfarin therapy in preventing unprovoked recurrent venous thromboembolism: A systematic review and meta-analysis.
    Jiang R; Shi Y; Zhang R; Pudasain B; Wang L; Zhao QH; Yuan P; Guo J; Zhu CT; Liu JM
    Clin Respir J; 2018 Jul; 12(7):2170-2177. PubMed ID: 29601145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
    Kearon C; Ginsberg JS; Kovacs MJ; Anderson DR; Wells P; Julian JA; MacKinnon B; Weitz JI; Crowther MA; Dolan S; Turpie AG; Geerts W; Solymoss S; van Nguyen P; Demers C; Kahn SR; Kassis J; Rodger M; Hambleton J; Gent M;
    N Engl J Med; 2003 Aug; 349(7):631-9. PubMed ID: 12917299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism.
    Svensson P; Södermark A; Schulman S
    Hematol J; 2002; 3(6):311-4. PubMed ID: 12522454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment.
    Pengo V; Barbero F; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
    Thromb Haemost; 2003 Apr; 89(4):760-4. PubMed ID: 12669133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty.
    Clark NP; Cho SE; Delate T; Witt DM
    Thromb Res; 2013 May; 131(5):390-5. PubMed ID: 23522854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative management of oral anticoagulation.
    O'Donnell M; Kearon C
    Cardiol Clin; 2008 May; 26(2):299-309, viii. PubMed ID: 18407002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.
    MacCallum PK; Brennan PJ; Meade TW
    Arch Intern Med; 2000 Sep; 160(16):2462-8. PubMed ID: 10979057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
    Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.